ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ProAgio enters human testing for Tough-to-Treat pancreatic cancer
Disease control OngoingThis is the first human study to test the safety of an experimental drug called ProAgio in people with advanced solid tumors, including pancreatic cancer, that have stopped responding to standard treatments. The main goal is to find a safe dose for future studies by giving ProAgi…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: ProDa BioTech, LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for tough cancer: early trial tests Four-Drug attack on pancreatic tumors
Disease control OngoingThis early-stage study is testing the safety and best dose of a new four-drug combination for people with advanced pancreatic cancer. The treatment mixes a new drug (AB680) with an immunotherapy drug and two standard chemotherapy drugs. The main goal is to see how well patients t…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Repurposed drug combo tested as new hope for tough cancers
Disease control OngoingThis is an early-stage study testing the safety of a combination of three existing drugs—metformin, digoxin, and simvastatin—in people with advanced pancreatic cancer or other solid tumors that have worsened despite standard treatment. The main goal is to find the highest dose pa…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Danae Hamouda, MD • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC